252 Phase I/II Study Combining Checkpoint Inhibitor (CPI) for Recurrent Glioblastoma (rGBM) at Various Timepoints Before or After Laser Interstitial Thermotherapy (LITT) With Incorporation of Integrated Biomarker (DVI)
Year: 2026
Type: conference-abstract
Source: Neurosurgery
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7140623749